Drugmaker Not Defamed By Medical Journal, 3rd Circ. Rules

By P.J. D'Annunzio · March 24, 2023, 9:57 PM EDT

A pharmaceutical company that sued a medical journal and several anesthesiologists over articles critical of one of its medications lost its appeal to revive the case Friday when the Third Circuit...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Pacira Biosciences Inc v. American Society of Anesthesiologists Inc, et al

Case Number

Court

Appellate - 3rd Circuit

Nature of Suit

4320 Assault, Libel, and Slander

Date Filed

March 09, 2022

Recent Articles By P.J.

June 13, 2024
CVS Dodges Discovery Audit In Generic Drug Collusion Suit
May 17, 2024
Philly Surgeon Settles Sex Bias Case With Jefferson Hospital
May 15, 2024
Former Sandoz Executive Avoids Prison In Price-Fixing Case
May 14, 2024
Hospitals Liable For Failing To Admit Killer, Pa. Justices Told
April 22, 2024
Citing Cozen O'Connor Ties, Pa. Judge Leaves Bias Case
April 15, 2024
Geico Must Arbitrate Fraud Claims Against Chiropractors
April 05, 2024
Surgeon Denied Atty Fees After Erasure of $15M Sex Bias Win
April 02, 2024
3rd Circ. Preview: Black Lung, Back Pay On Tap In April
March 22, 2024
Final OK Sought For Economic Loss Deal In CPAP Recall MDL
March 21, 2024
3rd Circ. Agrees Investors Have No Case Against Vax Maker